Reports and Surveys | February 10, 2020

2020 Investment Outlook: The Nice House in the Forest

For most investors, the last decade was like a nice walk along a wooded and scenic trail that ended with double-digit equity returns for 2019.

Those results, which were unexpectedly robust for holders of U.S. equity, were supported by four strong pillars: continued global economic growth, accommodative monetary policy, substantial share buyback activity and a booming technology sector.

Now, as we enter the new decade, most of those features appear to still be in place. However, numerous challenges still exist in the investment landscape, and investors would do well to stay vigilant. 

Get the Publication

2020 investment outlook Download Now

Questions about the investment outlook?

Get in touch. See how we can help. 

Contact Us

Over the next 12 to 18 months, here's what we expect.

Learn more about our global macroeconomic views and near-term performance expectations for specific asset classes.

Over the next 12 to 18 months, we expect*:

  • U.S. and developed non-U.S. equity to perform in-line with our long-term assumptions.
  • Emerging market equity to deliver returns that are slightly above normal. Normal returns for U.S. core fixed income and other areas of the U.S. bond market.
  • Below normal results for non-U.S. core bonds. Opportunities for emerging market debt to perform slightly better than normal.
  • Above-normal returns for energy, but below-normal for timber and private equity.

*The views represented for each of the asset classes are relative to our 10-year capital market assumptions.

See more insights

Senior Couple With Nordic Walking Poles Hiking In Snow Covered Winter Nature

Ontario’s Consultation on a New Funding Regime for MEPPs

Ontario’s Ministry of Finance proposes regulations for implementing a permanent target benefit framework for Multi-Employer Pension Plans (MEPPs).
Businessman Standing At Window In Conference Room

"2023: The Year of the Rabbit” Investment Outlook

As tough as 2022 was for financial assets, it has set up a very positive starting point for 2023. Get our insights in our latest Investment Outlook.
Male Pharmacist Assisting A Customer At The Prescription Counter

Ontario Drug Benefit Program Changes Biologics Coverage

Learn more about Ontario’s new policy on the use of biosimilars and see how this change might affect your plan.

Don't miss out. Join 16,000 others who already get the latest insights from Segal.